Rocket Pharmaceuticals Gene Therapy Investor Presentation

Rocket Pharmaceuticals is developing first-in-class and best-in-class gene therapies targeting rare genetic diseases including Fanconi Anemia, Leukocyte Adhesion Deficiency-I, Pyruvate Kinase Deficiency, and Danon Disease. The presentation outlines the company's pipeline progress, clinical trial timelines, and strategic approach to delivering curative treatments.